FORMULIERUNGEN EINES AXL/MER-INHIBITORS
European patent · EP3813800 · In force
Register entry
- Publication number
- EP3813800
- Application number
- EP19740291
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 28, 2019
- Published
- May 5, 2021
- Granted
- May 7, 2025
- Protection ends at the latest
- Jun 27, 2039
- Next annual fee due
- Jun 30, 2027
- IPC classes
- A61P 35/00 (2006.01)
- Priority
- US 201862692210 P 29.06.2018
- PCT application
- PCT/US2019/039825 28.06.2019
- PCT publication
- WO2020/006408 02.01.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Mar 18, 2026
Change
Published in Swissreg on 18.03.2026
- Jul 18, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 18.07.2025
- Jul 16, 2025
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 16.07.2025
- May 7, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 07.05.2025
Parties
Inventor
ROCCO, William L.
Wilmington, Delaware 19803, US
MULLER, Francis X.
Wilmington, Delaware 19803, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.